Systems biology based drug repositioning for development of cancer therapy

dc.authorid0000-0002-4858-8056
dc.authorid0000-0003-1330-9712
dc.contributor.authorTuranli, Beste
dc.contributor.authorAltay, Ozlem
dc.contributor.authorBoren, Jan
dc.contributor.authorTurkez, Hasan
dc.contributor.authorNielsen, Jens
dc.contributor.authorUhlen, Mathias
dc.contributor.authorArga, Kazim Yalcin
dc.date.accessioned2025-05-10T19:43:38Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractDrug repositioning is a powerful method that can assists the conventional drug discovery process by using existing drugs for treatment of a disease rather than its original indication. The first examples of repurposed drugs were discovered serendipitously, however data accumulated by high-throughput screenings and advancements in computational biology methods have paved the way for rational drug repositioning methods. As chemotherapeutic agents have notorious side effects that significantly reduce quality of life, drug repositioning promises repurposed noncancer drugs with little or tolerable adverse effects for cancer patients. Here, we review current drug-related data types and databases including some examples of web-based drug repositioning tools. Next, we describe systems biology approaches to be used in drug repositioning for effective cancer therapy. Finally, we highlight examples of mostly repurposed drugs for cancer treatment and provide an overview of future expectations in the field for development of effective treatment strategies.
dc.description.sponsorshipKnut and Alice Wallenberg Foundation
dc.description.sponsorshipWe would like to thank Stephen Doran and Simon Lam of King's College London for editorial comments. This work was supported by Knut and Alice Wallenberg Foundation.
dc.identifier.doi10.1016/j.semcancer.2019.09.020
dc.identifier.endpage58
dc.identifier.issn1044-579X
dc.identifier.issn1096-3650
dc.identifier.pmid31568815
dc.identifier.scopus2-s2.0-85072801840
dc.identifier.scopusqualityQ1
dc.identifier.startpage47
dc.identifier.urihttps://doi.org/10.1016/j.semcancer.2019.09.020
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10680
dc.identifier.volume68
dc.identifier.wosWOS:000616365300006
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAcademic Press Ltd- Elsevier Science Ltd
dc.relation.ispartofSeminars in Cancer Biology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectSystems biology
dc.subjectCancer
dc.subjectDrug repositioning
dc.subjectSignature-based approaches
dc.subjectNetwork-based approaches
dc.titleSystems biology based drug repositioning for development of cancer therapy
dc.typeReview

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
10680.pdf
Boyut:
1.14 MB
Biçim:
Adobe Portable Document Format